X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8880) 8880
Publication (995) 995
Book Chapter (73) 73
Book Review (63) 63
Conference Proceeding (17) 17
Dissertation (10) 10
Data Set (3) 3
Reference (2) 2
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5391) 5391
animals (4466) 4466
humans (4060) 4060
extracellular signal-regulated kinase (3106) 3106
extracellular signal-regulated map kinases - metabolism (2692) 2692
mice (2464) 2464
phosphorylation (2438) 2438
apoptosis (2362) 2362
signal transduction (2334) 2334
cell biology (2001) 2001
kinases (1948) 1948
inflammation (1933) 1933
proteins (1821) 1821
activation (1777) 1777
male (1675) 1675
biochemistry & molecular biology (1622) 1622
expression (1504) 1504
rats (1376) 1376
cells, cultured (1295) 1295
gene expression (1273) 1273
map kinase (1245) 1245
cytokines (1230) 1230
nf-kappa-b (1158) 1158
immunology (1148) 1148
rodents (1101) 1101
cancer (1059) 1059
female (1046) 1046
oxidative stress (1015) 1015
signal transduction - drug effects (1014) 1014
research article (1007) 1007
cell line (980) 980
medicine (973) 973
oncology (955) 955
cell line, tumor (923) 923
inhibition (923) 923
apoptosis - drug effects (885) 885
multidisciplinary sciences (872) 872
nf-kappa b - metabolism (856) 856
science (803) 803
pharmacology & pharmacy (779) 779
article (771) 771
neurosciences (765) 765
analysis (760) 760
cell proliferation (752) 752
gene-expression (751) 751
research (746) 746
signaling (731) 731
macrophages (719) 719
p38 mitogen-activated protein kinases - metabolism (710) 710
akt protein (701) 701
cells (693) 693
phosphorylation - drug effects (675) 675
signal-regulated kinase (671) 671
physiology (662) 662
tumor necrosis factor-α (622) 622
in-vitro (617) 617
health aspects (613) 613
map kinase signaling system - drug effects (607) 607
necrosis-factor-alpha (602) 602
tumor necrosis factor-tnf (602) 602
biology (601) 601
proto-oncogene proteins c-akt - metabolism (600) 600
activated protein-kinase (599) 599
transcription factors (595) 595
medicine, research & experimental (590) 590
physiological aspects (577) 577
mice, inbred c57bl (571) 571
blotting, western (565) 565
erk (558) 558
rats, sprague-dawley (557) 557
cell death (555) 555
tumor-necrosis-factor (542) 542
pathways (526) 526
tumor necrosis factor-alpha - metabolism (514) 514
protein kinases (505) 505
interleukin 6 (501) 501
mitogen-activated protein kinases - metabolism (497) 497
nf-κb protein (490) 490
tnf-alpha (488) 488
biochemistry (486) 486
nitric-oxide synthase (484) 484
cell proliferation - drug effects (482) 482
disease models, animal (480) 480
proliferation (471) 471
cell survival - drug effects (469) 469
enzyme activation (464) 464
jnk mitogen-activated protein kinases - metabolism (464) 464
extracellular signal-regulated map kinases - antagonists & inhibitors (462) 462
in-vivo (460) 460
lipopolysaccharides (452) 452
tumors (452) 452
enzyme inhibitors - pharmacology (450) 450
dose-response relationship, drug (449) 449
reactive oxygen species - metabolism (443) 443
enzyme activation - drug effects (434) 434
rna, messenger - metabolism (432) 432
up-regulation (429) 429
pathway (424) 424
studies (417) 417
time factors (417) 417
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8905) 8905
Chinese (15) 15
Japanese (11) 11
Korean (4) 4
Spanish (3) 3
German (2) 2
Polish (2) 2
Russian (2) 2
French (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 07/2017, Volume 102, Issue 1, pp. 19 - 29
TNF‐α stimulates exocytosis of secretory vesicles and gelatinase granules, and primes specific and azurophilic granule exocytosis that depend on p38 MAPK and... 
actin cytoskeleton | mass spectrometry | phosphorylation | p38 MAPK | P38 MAPK | Phosphorylation | Actin cytoskeleton | Mass spectrometry | RESPIRATORY BURST | ACTIVATED PROTEIN-KINASE | SECRETORY VESICLES | PLATELET SECRETION | REGULATED EXOCYTOSIS | MAST-CELLS | POLYMORPHONUCLEAR LEUKOCYTE | IMMUNOLOGY | BINDING PROTEIN | CELL BIOLOGY | DEGRANULATION | HEMATOLOGY | Gelatinases - immunology | Neutrophil Activation | Humans | Lipoylation - drug effects | Neutrophils - immunology | Protein Kinase C - immunology | p38 Mitogen-Activated Protein Kinases - immunology | Proto-Oncogene Proteins c-raf - immunology | Actin Cytoskeleton - immunology | Exocytosis - drug effects | Secretory Vesicles - immunology | Tumor Necrosis Factor-alpha - pharmacology | Exocytosis - immunology | alpha-Defensins - immunology | Tumor Necrosis Factor-alpha - immunology | Lipoylation - immunology | Proto-Oncogene Proteins c-abl - immunology | Protein kinase C | Leukemia | Stimulation | Kinases | Exocytosis | Proteins | Secretory vesicles | Vesicles | Actin | Phosphoproteins | Myosin | Tumor necrosis factor-TNF | Alanine | Immune response | Neutrophils | MAP kinase | Priming | Mass spectroscopy | Pharmacology | Gelatinase | Tumor necrosis factor-α | Substrates | Granular materials | Cytoskeleton | Granules | MARCKS protein | Index Medicus | Spotlight on Leading Edge Research
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 11/2013, Volume 288, Issue 45, pp. 32343 - 32356
Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown efficacy in a phase 2 clinical trial, development of resistance to TRAIL by... 
Reactive Oxygen Species (ROS) | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOWN-REGULATION | MEDIATED APOPTOSIS | Limonoid | ANTITUMOR-ACTIVITY | Cancer Therapy | MAP Kinases (MAPKs) | Death Receptor | Trail | MELIA-AZADIRACHTA L | CHOP | CHOLANGIOCARCINOMA CELLS | SURVIVAL PROTEINS | NF-KAPPA-B | UP-REGULATION | APO2L/TRAIL-INDUCED APOPTOSIS | Anticancer Drug | COLON-CARCINOMA | Apoptosis | Neoplasms - metabolism | Transcription Factor CHOP - genetics | Reactive Oxygen Species - metabolism | Humans | Extracellular Signal-Regulated MAP Kinases - metabolism | Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism | Extracellular Signal-Regulated MAP Kinases - genetics | Tumor Suppressor Protein p53 - genetics | Dose-Response Relationship, Drug | TNF-Related Apoptosis-Inducing Ligand - pharmacology | Neoplasms - genetics | Antineoplastic Agents - pharmacology | Receptors, TNF-Related Apoptosis-Inducing Ligand - genetics | Gene Expression Regulation, Neoplastic - drug effects | Apoptosis Regulatory Proteins - biosynthesis | Response Elements | Cell Survival | Tumor Suppressor Protein p53 - metabolism | Down-Regulation - drug effects | Neoplasms - drug therapy | Up-Regulation - drug effects | Limonins - pharmacology | MAP Kinase Signaling System - drug effects | Cell Line, Tumor | Neoplasms - pathology | Transcription Factor CHOP - metabolism | Signal Transduction
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 1365 - 13
Despite anti-TNF therapy advancements for inflammatory diseases such as rheumatoid arthritis, the burden of diseases remains high. An 11-mer TNF peptide,... 
RHEUMATOID-ARTHRITIS | ACTIVATION | POLYUNSATURATED FATTY-ACID | HUMAN NEUTROPHILS | P38 | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | HOST-DEFENSE | TNF-ALPHA | LONG-CHAIN | RESPIRATORY SYNCYTIAL VIRUS | Neutrophils - cytology | Arthritis, Experimental - drug therapy | Arthritis, Experimental - genetics | Humans | Pneumonia, Viral - drug therapy | Respiratory Syncytial Viruses - immunology | Tumor Necrosis Factor-alpha - genetics | Lipopolysaccharides - antagonists & inhibitors | Anti-Inflammatory Agents - metabolism | Peritonitis - pathology | Pneumonia, Viral - genetics | Peritonitis - genetics | Tumor Necrosis Factor-alpha - immunology | Pneumonia - immunology | Peptide Fragments - genetics | Disease Models, Animal | Pneumonia - genetics | Signal Transduction | Anti-Inflammatory Agents - pharmacology | Neutrophils - drug effects | p38 Mitogen-Activated Protein Kinases - immunology | Peptide Fragments - biosynthesis | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Lipopolysaccharides - pharmacology | Platelet Glycoprotein GPIb-IX Complex - genetics | Mice | Mice, Inbred BALB C | Peritonitis - drug therapy | Respiratory Syncytial Viruses - pathogenicity | Pneumonia - pathology | Peptide Fragments - pharmacology | Respiratory Burst - drug effects | Arthritis, Experimental - pathology | Receptors, Tumor Necrosis Factor - antagonists & inhibitors | Female | Receptors, Tumor Necrosis Factor - genetics | Pneumonia, Viral - pathology | Gene Expression Regulation | Neutrophils - immunology | p38 Mitogen-Activated Protein Kinases - genetics | Arthritis, Experimental - immunology | Peritonitis - immunology | Pneumonia, Viral - immunology | Animals | Anti-Inflammatory Agents - chemistry | Pneumonia - drug therapy | Protein Binding | Receptors, Tumor Necrosis Factor - immunology | Platelet Glycoprotein GPIb-IX Complex - immunology | Tumor necrosis factor receptors | NF-κB protein | Peptides | Extracellular signal-regulated kinase | MAP kinase | Viruses | JNK protein | Activation | Leukocytes (neutrophilic) | Inflammation | T cell receptors | Arthritis | Inflammatory diseases | Mutants | Signal transduction | Signaling | Lungs | Tumor necrosis factor | Rheumatoid arthritis | Tumor necrosis factor-TNF | Respiratory burst | Carrageenan | Peritonitis | Tumors
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 08/2011, Volume 31, Issue 8, pp. 1890 - 1897
Journal Article
Cardiovascular Research, ISSN 0008-6363, 11/2009, Volume 84, Issue 2, pp. 201 - 208
Aims Ischaemic postconditioning (IPostC) is a powerful protective phenomenon that activates prosurvival intrinsic signalling cascades to limit reperfusion... 
Ischaemia | Infarction | Reperfusion | Postconditioning | Preconditioning | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | NECROSIS-FACTOR-ALPHA | CARDIAC MYOCYTE | MURINE MODEL | ISOLATED MOUSE HEARTS | INDUCED CARDIOPROTECTION | ACUTE MYOCARDIAL-INFARCTION | TNF-ALPHA | PROSURVIVAL KINASES | SIGNAL TRANSDUCER | Tumor Necrosis Factor-alpha - metabolism | Phosphorylation | Tumor Necrosis Factor-alpha - genetics | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Glycogen Synthase Kinase 3 beta | Male | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Receptors, Tumor Necrosis Factor, Type I - metabolism | Tumor Necrosis Factor-alpha - deficiency | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Myocardial Reperfusion Injury - pathology | Receptors, Tumor Necrosis Factor, Type II - metabolism | Myocardial Infarction - pathology | Myocardium - metabolism | STAT3 Transcription Factor - deficiency | Flavonoids - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | STAT3 Transcription Factor - genetics | STAT3 Transcription Factor - metabolism | Disease Models, Animal | Mice, Inbred C57BL | Myocardium - pathology | Tyrphostins - pharmacology | Myocardial Infarction - metabolism | Glycogen Synthase Kinase 3 - metabolism | Receptors, Tumor Necrosis Factor, Type I - genetics | Receptors, Tumor Necrosis Factor, Type II - genetics | Mice, Knockout | Receptors, Tumor Necrosis Factor, Type II - deficiency | Myocardial Reperfusion Injury - metabolism | Animals | Androstadienes - pharmacology | Signal Transduction - drug effects | Mice | Myocardial Infarction - prevention & control | Protein Kinase Inhibitors - pharmacology | STAT3 Transcription Factor - antagonists & inhibitors | Myocardial Reperfusion Injury - prevention & control | Proto-Oncogene Proteins c-akt - antagonists & inhibitors
Journal Article
Journal Article